Wells Fargo Downgrades Monte Rosa Therapeutics(GLUE.US) to Hold Rating, Cuts Target Price to $11

Futu NewsDec 21 01:32 · Ratings

Wells Fargo Downgrades Monte Rosa Therapeutics to Equal-Weight, Lowers Price Target to $11

BenzingaDec 19 20:38 · Ratings

Monte Rosa Therapeutics Analyst Ratings

BenzingaDec 19 20:35 · Ratings

Press Release: Monte Rosa Therapeutics Appoints Dr. Eric A. Hughes to Board of Directors

Dow JonesDec 13 20:00

Express News | Monte Rosa Therapeutics Appoints DR. Eric a. Hughes to Board of Directors

BreakingsDec 13 20:00

Monte Rosa Closes Global License Agreement With Novartis

MT NewswiresDec 11 20:45